OTCMKTS:EKTAY Elekta AB (publ) (EKTAY) Stock Price, News & Analysis → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free EKTAY Stock Alerts $6.92 -0.13 (-1.84%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$6.90▼$6.9250-Day Range$6.73▼$7.8252-Week Range$6.52▼$8.65Volume8,258 shsAverage Volume8,129 shsMarket Capitalization$2.65 billionP/E Ratio19.22Dividend Yield2.31%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesShort Interest Get Elekta AB (publ) alerts: Email Address Elekta AB (publ) MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.00% of Shares Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth14.63%From $0.41 to $0.47 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.14 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Elekta AB (publ). Previous Next 3.0 Short Interest Percentage of Shares Shorted0.00% of the outstanding shares of Elekta AB (publ) have been sold short.Short Interest Ratio / Days to CoverElekta AB (publ) has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Elekta AB (publ) has recently increased by 71.43%, indicating that investor sentiment is decreasing significantly. Previous Next 2.5 Dividend Strength Dividend YieldElekta AB (publ) pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthElekta AB (publ) does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Elekta AB (publ) is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Elekta AB (publ) will have a dividend payout ratio of 34.04% next year. This indicates that Elekta AB (publ) will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EKTAY. Previous Next 2.8 News and Social Media Coverage News SentimentElekta AB (publ) has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.MarketBeat Follows1 people have added Elekta AB (publ) to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Elekta AB (publ) insiders have not sold or bought any company stock.Percentage Held by Insiders41.28% of the stock of Elekta AB (publ) is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Elekta AB (publ) are expected to grow by 14.63% in the coming year, from $0.41 to $0.47 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Elekta AB (publ) is 19.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 146.45.Price to Earnings Ratio vs. SectorThe P/E ratio of Elekta AB (publ) is 19.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 258.94.Price to Book Value per Share RatioElekta AB (publ) has a P/B Ratio of 2.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Elekta AB (publ) Stock (OTCMKTS:EKTAY)Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.Read More EKTAY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EKTAY Stock News HeadlinesMarch 1, 2024 | gurufocus.comQ3 2024 Elekta AB (publ) Earnings Call TranscriptFebruary 23, 2024 | msn.comElekta AB (publ) goes ex dividend MondayApril 25, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.February 20, 2024 | finance.yahoo.comIs Elekta (EKTAY) Stock Undervalued Right Now?December 17, 2023 | msn.comElekta AB - ADR (EKTAY) Price Target Increased by 5.21% to 8.43December 7, 2023 | finance.yahoo.comIs Elekta (EKTAY) a Great Value Stock Right Now?November 27, 2023 | msn.comElekta AB - ADR (EKTAY) Price Target Increased by 6.97% to 8.01November 9, 2023 | morningstar.comElekta AB ADR EKTAYApril 25, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.November 8, 2023 | msn.comElekta gets $40m radiation tech contract from India’s KIMSOctober 23, 2023 | stockhouse.comiCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to ElektaAugust 26, 2023 | seekingalpha.comElekta AB (publ) 2024 Q1 - Results - Earnings Call PresentationAugust 26, 2023 | seekingalpha.comElekta AB (publ) (EKTAF) Q1 2024 Earnings Call TranscriptJuly 19, 2023 | wsj.comElekta AB Series BApril 30, 2023 | seekingalpha.comEpiroc AB (publ) 2023 Q1 - Results - Earnings Call PresentationNovember 24, 2022 | finance.yahoo.comEuropean shares struggle for direction as traders weigh rate outlookNovember 5, 2022 | finance.yahoo.comElekta AB (publ) (EKTAY)October 13, 2022 | finance.yahoo.comElekta AB (publ) (EKTA-B.ST)October 9, 2022 | fool.comELEKTA B SHS ADR (OTC: EKTAY)October 2, 2022 | reuters.comElekta AB (publ)August 27, 2022 | seekingalpha.comElekta AB (publ) 2023 Q1 - Results - Earnings Call PresentationAugust 25, 2022 | seekingalpha.comElekta AB (publ) (EKTAF) Q1 2023 Earnings Call TranscriptAugust 25, 2022 | finance.yahoo.comEdited Transcript of EKTAb.ST earnings conference call or presentation 25-Aug-22 8:00am GMTMay 15, 2022 | seekingalpha.comElekta (EKTAY) Presents at ESTRO 2022February 24, 2022 | finance.yahoo.comElekta: Interim report, May-January 2021/22January 7, 2022 | seekingalpha.comNew finance chief at ElektaJanuary 7, 2022 | finance.yahoo.comElekta to appoint Tobias Hägglöv as Chief Financial OfficerSee More Headlines Receive EKTAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/18 Dividend2/26/2024Last Earnings2/29/2024Dividend Payable3/18/2024Today4/24/2024Fiscal Year End4/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolOTCMKTS:EKTAY CUSIPN/A CIK1451160 Webwww.elekta.com Phone(685) 872-5400Fax46-8-587-255-00Employees4,540Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.36 Trailing P/E Ratio19.22 Forward P/E Ratio16.88 P/E GrowthN/ANet Income$90.25 million Net Margins7.88% Pretax Margin8.25% Return on Equity15.16% Return on Assets5.01% Debt Debt-to-Equity Ratio0.57 Current Ratio1.12 Quick Ratio0.83 Sales & Book Value Annual Sales$1.61 billion Price / Sales1.64 Cash Flow$0.56 per share Price / Cash Flow12.36 Book Value$2.43 per share Price / Book2.85Miscellaneous Outstanding Shares383,570,000Free Float225,231,000Market Cap$2.65 billion OptionableNot Optionable Beta1.16 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Laurent Leksell (Age 72)Founder & Chairman Comp: $1.64MMr. Gustaf Salford (Age 47)President & CEO Comp: $14.62MMr. Tobias Hagglov (Age 46)Chief Financial Officer Mr. Peter Nyquist (Age 59)Head of Investor Relations Mr. Jonas Bolander (Age 58)Executive VP of Group Functions, Secretary & General Counsel Mr. Mattias ThorssonVP and Head of Corporate Communications & Public AffairsMs. Anna Conneryd Lundgren (Age 39)Executive VP & Chief People Officer Mr. John Lapré (Age 60)President of Brachy & Neuro Solutions Mr. Maurits Wolleswinkel (Age 53)President of Linac & Software Solutions Mr. Habib Nehme (Age 60)Chief Commercial Officer More ExecutivesKey CompetitorsRadNetNASDAQ:RDNTGuardant HealthNASDAQ:GHFortreaNASDAQ:FTREVeracyteNASDAQ:VCYTViridian TherapeuticsNASDAQ:VRDNView All Competitors EKTAY Stock Analysis - Frequently Asked Questions Should I buy or sell Elekta AB (publ) stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street research analysts is that investors should "sell" EKTAY shares. View EKTAY analyst ratings or view top-rated stocks. How have EKTAY shares performed in 2024? Elekta AB (publ)'s stock was trading at $8.1495 at the start of the year. Since then, EKTAY stock has decreased by 15.1% and is now trading at $6.92. View the best growth stocks for 2024 here. Are investors shorting Elekta AB (publ)? Elekta AB (publ) saw a increase in short interest in March. As of March 31st, there was short interest totaling 2,400 shares, an increase of 71.4% from the March 15th total of 1,400 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio is currently 0.3 days. View Elekta AB (publ)'s Short Interest. How were Elekta AB (publ)'s earnings last quarter? Elekta AB (publ) (OTCMKTS:EKTAY) announced its quarterly earnings data on Thursday, February, 29th. The company reported $0.08 EPS for the quarter. The business earned $426.51 million during the quarter. Elekta AB (publ) had a net margin of 7.88% and a trailing twelve-month return on equity of 15.16%. How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)? Elekta AB (publ) announced a dividend on Tuesday, January 30th. Shareholders of record on Tuesday, February 27th will be paid a dividend of $0.1146 per share on Monday, March 18th. The ex-dividend date is Monday, February 26th. Read our dividend analysis for EKTAY. Is Elekta AB (publ) a good dividend stock? Elekta AB (publ) (OTCMKTS:EKTAY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EKTAY will have a dividend payout ratio of 34.04% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for EKTAY. How do I buy shares of Elekta AB (publ)? Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EKTAY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elekta AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.